BostonGene Announces Ten Presentations at the 65th American Society of Hematology Annual Meeting & Exposition Presentations with Leading Institutions Reveal BostonGene’s AI-driven Molecular and ...
LEXINGTON, Mass., Nov. 4, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results